Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model.
- DOI
- 10.1182/bloodadvances.2025019559
- Published
- 2026 Aug 7
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2025019559,
title = {Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model.},
author = {Firoz WA and Sheng MK and Ruivo P and Vick LV and Collins CP and Nielsen RN and Shah RK and Khuat LT and Xiong Y and Dave M and Judge SJ and Canter RJ and Monjazeb AM and Blazar BR and Zamora AE and Murphy WJ},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2025019559},
url = {https://doi.org/10.1182/bloodadvances.2025019559}
}RIS
TY - JOUR TI - Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model. AU - Firoz WA AU - Sheng MK AU - Ruivo P AU - Vick LV AU - Collins CP AU - Nielsen RN AU - Shah RK AU - Khuat LT AU - Xiong Y AU - Dave M AU - Judge SJ AU - Canter RJ AU - Monjazeb AM AU - Blazar BR AU - Zamora AE AU - Murphy WJ PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2025019559 UR - https://doi.org/10.1182/bloodadvances.2025019559 ER -
APA
WA, F., MK, S., P, R., LV, V., CP, C., RN, N., RK, S., LT, K., Y, X., M, D., SJ, J., RJ, C., AM, M., BR, B., AE, Z., & WJ, M. (2026). Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model.. Blood advances. https://doi.org/10.1182/bloodadvances.2025019559
Source records
- pubmed · retrieved 2026-09-26T06:05:02.447Z